Response to Joob and Wiwanitkit Re: “AA IDO1 Variant Genotype (G2431A,rs3739319) Is Associated with Severe Dengue Risk Development in a DEN-3 Brazilian Cohort”
Restricted accessLetterFirst published online September, 2019
Response to Joob and Wiwanitkit Re: “AA IDO1 Variant Genotype (G2431A,rs3739319) Is Associated with Severe Dengue Risk Development in a DEN-3 Brazilian Cohort”
Acioli-SantosB, SegatL, DhaliaR, et al.MBL2 gene polymorphisms protect against development of thrombocytopenia associated with severe dengue phenotype. Hum Immunol, 2008; 69122–128.
2.
AzevedoBP, FariasPCS, PastorAF, et al.AA IDO1 variant genotype (G2431A, rs3739319) is associated with severe dengue risk development in a DEN-3 Brazilian cohort. Viral Immunol, 2019; 14:296–301.
3.
DaviCCM, PastorAF, OliveiraT, et al.Severe dengue prognosis using human genome data and machine learning. IEEE Trans Biomed Eng, 2019; 4:1–8.
4.
JoobB, WiwanitkitV. Interleukin-2-330T/G and Interleukin-10-1082A/G genetic polymorphisms and B-cell non-Hodgkin lymphoma. Turk J Haematol, 2018; 35:301–302.
5.
JoobB, WiwanitkitV. Re: “AA IDO1 variant genotype (G2431A, rs3739319) is associated with severe dengue risk development in a DEN-3 Brazilian Cohort” by Azevedo et al. (Viral Immunol 2019;14:296–301). Viral Immunol, 2019; 14:318.
6.
LeePH, ShatkayH. F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res, 2008; 36 (Database Issue):D820–D824.
7.
PanoutsopoulouK, WalterK. Quality control of common and rare variants. Methods Mol Biol, 2018; 1793:25–36.